In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination.
<h4>Background</h4>Schistosomiasis is a neglected disease affecting hundreds of millions worldwide. Of the three main species affecting humans, Schistosoma haematobium is the most common, and is the leading cause of urogenital schistosomiasis. S. haematobium infection can cause different...
Saved in:
Main Authors: | Javier Sotillo (Author), Mark S Pearson (Author), Luke Becker (Author), Gebeyaw G Mekonnen (Author), Abena S Amoah (Author), Govert van Dam (Author), Paul L A M Corstjens (Author), Janice Murray (Author), Takafira Mduluza (Author), Francisca Mutapi (Author), Alex Loukas (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers.
by: Gebeyaw G Mekonnen, et al.
Published: (2022) -
Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
by: Kate M Mitchell, et al.
Published: (2014) -
Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children.
by: Derick N M Osakunor, et al.
Published: (2020) -
Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012) -
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011)